These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 19302179

  • 1. Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C.
    Kawaguchi Y, Mizuta T, Oza N, Takahashi H, Ario K, Yoshimura T, Eguchi Y, Ozaki I, Hisatomi A, Fujimoto K.
    Liver Int; 2009 Jul; 29(6):871-7. PubMed ID: 19302179
    [Abstract] [Full Text] [Related]

  • 2. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.
    Kawaguchi T, Ide T, Taniguchi E, Hirano E, Itou M, Sumie S, Nagao Y, Yanagimoto C, Hanada S, Koga H, Sata M.
    Am J Gastroenterol; 2007 Mar; 102(3):570-6. PubMed ID: 17222321
    [Abstract] [Full Text] [Related]

  • 3. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
    Poustchi H, Negro F, Hui J, Cua IH, Brandt LR, Kench JG, George J.
    J Hepatol; 2008 Jan; 48(1):28-34. PubMed ID: 17977612
    [Abstract] [Full Text] [Related]

  • 4. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S, Cammà C, Di Marco V, Cabibi D, Ciminnisi S, Caldarella R, Licata A, Massenti MF, Marchesini G, Craxì A.
    Antivir Ther; 2009 Jan; 14(5):631-9. PubMed ID: 19704165
    [Abstract] [Full Text] [Related]

  • 5. Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients.
    Taura N, Ichikawa T, Hamasaki K, Nakao K, Nishimura D, Goto T, Fukuta M, Kawashimo H, Fujimoto M, Kusumoto K, Motoyoshi Y, Shibata H, Abiru N, Yamasaki H, Eguchi K.
    Am J Gastroenterol; 2006 Dec; 101(12):2752-9. PubMed ID: 17026566
    [Abstract] [Full Text] [Related]

  • 6. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
    Durante-Mangoni E, Zampino R, Marrone A, Tripodi MF, Rinaldi L, Restivo L, Cioffi M, Ruggiero G, Adinolfi LE.
    Aliment Pharmacol Ther; 2006 Nov 01; 24(9):1349-57. PubMed ID: 17059516
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation.
    Eguchi Y, Mizuta T, Ishibashi E, Kitajima Y, Oza N, Nakashita S, Hara M, Iwane S, Takahashi H, Akiyama T, Ario K, Kawaguchi Y, Yasutake T, Iwakiri R, Ozaki I, Hisatomi A, Eguchi T, Ono N, Fujimoto K.
    Liver Int; 2009 Feb 01; 29(2):213-20. PubMed ID: 18710430
    [Abstract] [Full Text] [Related]

  • 8. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
    Helaly GF, Hussein NG, Refai W, Ibrahim M.
    Transl Res; 2011 Sep 01; 158(3):155-62. PubMed ID: 21867981
    [Abstract] [Full Text] [Related]

  • 9. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.
    Knobler H, Zhornicky T, Sandler A, Haran N, Ashur Y, Schattner A.
    Am J Gastroenterol; 2003 Dec 01; 98(12):2751-6. PubMed ID: 14687828
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
    Imazeki F, Yokosuka O, Fukai K, Kanda T, Kojima H, Saisho H.
    Liver Int; 2008 Mar 01; 28(3):355-62. PubMed ID: 18290778
    [Abstract] [Full Text] [Related]

  • 11. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
    Crinò A, Di Giorgio G, Manco M, Grugni G, Maggioni A.
    Horm Res; 2007 Mar 01; 68(2):83-90. PubMed ID: 17337902
    [Abstract] [Full Text] [Related]

  • 12. Effect of interferon treatment on glucose metabolism in children with chronic hepatitis B infection.
    Kuloğlu Z, Kansu A, Berberoğlu M, Demirçeken F, Ocal G, Girgin N.
    Turk J Gastroenterol; 2004 Mar 01; 15(1):4-10. PubMed ID: 15264114
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy.
    Makiyama A, Itoh Y, Kasahara A, Imai Y, Kawata S, Yoshioka K, Tsubouchi H, Kiyosawa K, Kakumu S, Okita K, Hayashi N, Okanoue T.
    Cancer; 2004 Oct 01; 101(7):1616-22. PubMed ID: 15378504
    [Abstract] [Full Text] [Related]

  • 14. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS, Liu CH, Liu CJ, Wang CC, Chen CL, Lai MY, Chen PJ, Chen DS, Kao JH.
    Am J Gastroenterol; 2009 Mar 01; 104(3):598-604. PubMed ID: 19262519
    [Abstract] [Full Text] [Related]

  • 15. Insulin resistance in chronic hepatitis B virus infection.
    Kumar M, Choudhury A, Manglik N, Hissar S, Rastogi A, Sakhuja P, Sarin SK.
    Am J Gastroenterol; 2009 Jan 01; 104(1):76-82. PubMed ID: 19098853
    [Abstract] [Full Text] [Related]

  • 16. Changes in serum lipid concentrations in patients with chronic hepatitis C virus positive hepatitis responsive or non-responsive to interferon therapy.
    Hamamoto S, Uchida Y, Wada T, Moritani M, Sato S, Hamamoto N, Ishihara S, Watanabe M, Kinoshita Y.
    J Gastroenterol Hepatol; 2005 Feb 01; 20(2):204-8. PubMed ID: 15683422
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients.
    Yoneda M, Saito S, Ikeda T, Fujita K, Mawatari H, Kirikoshi H, Inamori M, Nozaki Y, Akiyama T, Takahashi H, Abe Y, Kubota K, Iwasaki T, Terauchi Y, Togo S, Nakajima A.
    J Viral Hepat; 2007 Sep 01; 14(9):600-7. PubMed ID: 17697011
    [Abstract] [Full Text] [Related]

  • 18. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
    Hsu CS, Liu CJ, Liu CH, Wang CC, Chen CL, Lai MY, Chen PJ, Kao JH, Chen DS.
    Liver Int; 2008 Feb 01; 28(2):271-7. PubMed ID: 18028320
    [Abstract] [Full Text] [Related]

  • 19. Changes in glucose tolerance after interferon-alpha therapy in patients with chronic hepatitis C.
    Tanaka H, Shiota G, Kawasaki H.
    J Med; 1997 Feb 01; 28(5-6):335-46. PubMed ID: 9604792
    [Abstract] [Full Text] [Related]

  • 20. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
    Anty R, Gelsi E, Giudicelli J, Mariné-Barjoan E, Gual P, Benzaken S, Saint-Paul MC, Sadoul JL, Huet PM, Tran A.
    Eur J Gastroenterol Hepatol; 2007 Aug 01; 19(8):671-7. PubMed ID: 17625437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.